New Drug Approved for Early Alzheimer’s
Jul 02, 2024
The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.
https://www.nytimes.com/2024/07/02/health/alzheimers-treatment-kisunla-donanemab.html
One Click to Comment and Customize your news.

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service